Dr. Denis Archambault is a faculty member of the Department of Biological Sciences at the University of Québec at Montréal (UQAM) since 1991. He is specialized in RNA viruses (retroviruses, arteriviruses/coronaviruses, influenza virus) and vaccine development. He holds DVM and PhD degrees from University of Montreal. He has completed postdoctoral studies at the prestigious National Institute of Health (NIH) in Bethesda, Maryland (USA), and at the National Laboratory of Immunology in Ottawa (Canada) through fellowships from the Canadian Institutes of Health Research (CIHR) . Then he held a research scholarship from the Fonds de la Recherche en Santé du Québec from 1990 to 2002, while occupying his professor position at UQAM. He also has obtained a MBA degree from Sherbrooke University in 2001. In addition to his commitment in serving on grant review committees and as reviewer for various scientific journals, he has served on the editorial board of "Veterinary Research"​ from 1994 to 2009). He also has been appointed "Lead Guest Editor"​ for a special issue on arteriviruses that appeared in March 2014 in the journal "BioMed Research International". His current research work involves studies on new-generation nanovaccine development and virus-host cell interactions. His scientific record shows 94 scientific publications (see Research Scholar and PubMed), 186 presentations at scientific meetings and 80 presentations/seminars, many of them as guest speaker.